Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies. [electronic resource]
Producer: 20201007Description: 881-887 p. digitalISSN:- 1534-6080
- Adult
- Biomarkers -- blood
- Calcineurin Inhibitors -- adverse effects
- Drug Monitoring
- Female
- Graft Rejection -- diagnosis
- Graft Survival -- drug effects
- HLA Antigens -- immunology
- Humans
- Immunosuppressive Agents -- adverse effects
- Isoantibodies -- blood
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Predictive Value of Tests
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Tacrolimus -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.